ARK Genomic Revolution ETF (ARKG)
BATS: ARKG · Real-Time Price · USD
30.67
+0.14 (0.46%)
May 22, 2026, 4:00 PM EDT - Market closed
ARKG Holdings Information
ARKG is an equity ETF with a total of 33 individual holdings. The top holdings are Twist Bioscience stock at 8.53%, CRISPR Therapeutics AG at 8.28%, Tempus AI at 8.02%, 10x Genomics at 6.21%, and Personalis at 5.25%.
Total Holdings
33
Top 10 Percentage
59.35%
Asset Class
Equity
ETF Category
Health
Assets
1.13B
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TWST | Twist Bioscience Corporation | 8.53% |
| 2 | CRSP | CRISPR Therapeutics AG | 8.28% |
| 3 | TEM | Tempus AI, Inc. | 8.02% |
| 4 | TXG | 10x Genomics, Inc. | 6.21% |
| 5 | PSNL | Personalis, Inc. | 5.25% |
| 6 | BEAM | Beam Therapeutics Inc. | 4.83% |
| 7 | ABSI | Absci Corporation | 4.81% |
| 8 | GH | Guardant Health, Inc. | 4.65% |
| 9 | ILMN | Illumina, Inc. | 4.52% |
| 10 | NTRA | Natera, Inc. | 4.25% |
| 11 | VCYT | Veracyte, Inc. | 3.44% |
| 12 | NTLA | Intellia Therapeutics, Inc. | 3.39% |
| 13 | CDNA | CareDx, Inc. | 3.21% |
| 14 | RXRX | Recursion Pharmaceuticals, Inc. | 3.10% |
| 15 | CMPS | COMPASS Pathways plc | 3.05% |
| 16 | NRIX | Nurix Therapeutics, Inc. | 2.40% |
| 17 | ADPT | Adaptive Biotechnologies Corporation | 2.24% |
| 18 | SDGR | Schrödinger, Inc. | 2.20% |
| 19 | BFLY | Butterfly Network, Inc. | 1.74% |
| 20 | IONS | Ionis Pharmaceuticals, Inc. | 1.73% |
| 21 | WGS | GeneDx Holdings Corp. | 1.72% |
| 22 | CERS | Cerus Corporation | 1.61% |
| 23 | ARCT | Arcturus Therapeutics Holdings Inc. | 1.57% |
| 24 | ATAI | AtaiBeckley Inc. | 1.51% |
| 25 | PRME | Prime Medicine, Inc. | 1.15% |
As of May 22, 2026